Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of The Combination of Vismodegib and Sirolimus

NCT01537107 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01537107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01537107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of The Combination of Vismodegib and Sirolimus
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
March 5, 2012
Completion date
June 27, 2018
Enrollment
31 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acinar cell adenocarcinoma of the pancreas, duct cell adenocarcinoma of the pancreas, recurrent pancreatic cancer, stage iv pancreatic cancer, unspecified adult solid tumor, protocol specific